Important Appointment at Boehringer Ingelheim

Boehringer Ingelheim Turkey Financial Controller Umut Eken Promoted to Controller Role in IMETA Region Umut Eken, serving as Financial Controller at Boehringer Ingelheim Turkey, has been appointed as Controller for the India, Middle East, Turkey, Africa (IMETA) Region Human Health Business Unit, headquartered in Dubai. Boehringer Ingelheim, which drives innovation across three business areas—human, animal and biopharmaceuticals—and ranks among the world's leading research-focused pharmaceutical companies, continues to make global appointments from its Turkish organization. The company has announced that Umut Eken has been appointed as Controller to the Boehringer Ingelheim IMETA Region Human Health Business Unit, headquartered in Dubai. Umut Eken joined Boehringer Ingelheim Turkey in 2020 and served as Financial Controller in the Human Health area. During his tenure, he has achieved significant accomplishments through his contributions to the company.     Umut Eken Umut Eken began his career in 2010 as Financial Reporting & Control Specialist at Real Hypermarkets Chain and continued in this role until September 2011. Between September 2011 and November 2013, he served as Financial Analysis and Budget Reporting Specialist at Ströer Out-of-Home Media AG. Eken started as Financial Controller at BSH Home Appliances in December 2013 and concluded his tenure as Financial Control Manager in September 2017. Until April 2020, he served as Global Budget Planning and Finance Manager at Hayat Kimya. In 2020, he joined Boehringer Ingelheim Turkey Human Health Business Unit as Financial Controller.   About Boehringer Ingelheim is committed to developing groundbreaking treatments that improve the lives of people and animals. As a leading research-focused biopharmaceutical company, it creates value through innovation in addressing unmet healthcare needs. Since its founding in 1885, the company has maintained its family business identity while adopting a long-term approach to its work. With approximately 52,000 employees, it operates in more than 130 markets across three business areas: Human Health, Animal Health, and Biopharmaceuticals. www.boehringer-ingelheim.com.